Elevance Well being (NYSE: ELV) continues to focus on the capabilities of its suppliers – together with dwelling well being companies – as a strategic precedence.

The corporate is working with personal fairness agency Clayton, Dubilier & Rice (CD&R) on a major care initiative that can convey collectively Carelon Well being – Elevance Well being's supplier – and Apree Well being and Millennium Doctor group, two CD&R-backed firms.

“CD&R's partnership with Elevance Well being is a vital step in our continued funding focus to speed up innovation in healthcare supply throughout the nation,” Clay Richards, a CD&R working associate, mentioned in a information launch Monday. “We’re excited to enter into this strategic partnership with Elevance Well being and see what this effort can obtain, leveraging the strengths of every of the three firms to enhance the affected person and doctor expertise for the communities they serve .”

The initiative is particularly aimed toward a “entire well being method” to major care, specializing in the bodily, social and behavioral well being wants of sufferers.

Elevance Well being Gail Boudreaux expanded on the partnership Thursday in her firm's first-quarter earnings name.

“We’re excited to associate with CD&R and a broad vary of healthcare suppliers to speed up innovation, enhance healthcare experiences and enhance well being outcomes for shoppers,” mentioned Boudreaux. “The co-development of the corporate will advance our company technique by accelerating the supply of value-based care to our members and shoppers extra broadly, with our Carelon companies offering alternatives to combine and personalize the care delivered.”

Finally, Elevance Well being plans to completely personal what comes out of the partnership, and Boudreaux expects it is going to be a “main platform for value-based care” for all payer teams.

Within the first quarter, Elevance Well being posted working revenues of $42.3 billion, which was up 0.9% yr over yr.

Carelon, however, generated $12.1 billion in working income within the first quarter, up $600 million or about 5% yr over yr.

Elevance Well being additionally lately strengthened its supplier capabilities with the acquisition of Paragon Healthcare, an infusion supplier that additionally offers in-home care.

“Within the first quarter, we made tangible progress on our strategic initiatives, significantly in Carelon, the place we proceed to scale our flywheel for enterprise development,” mentioned Boudreaux. “Carelon has accomplished the acquisition of Paragon Healthcare, a number one supplier of infusion companies. We sit up for increasing geographic attain and therapeutic protection to serve extra shoppers and Elevance Well being members within the years to come back.”

Elevance Well being actually has its arms in dwelling well being care throughout its portfolio, however hasn't totally dived into it but.

Nevertheless, current acquisitions and launched initiatives could also be an indication of issues to come back.